Skip to main content
PMC home page
The Texas Heart Institute Journal logoLink to The Texas Heart Institute Journal
. 1996;23(2):122–127.

New applications of myocardial perfusion imaging.

E G DePuey 1
PMCID: PMC325326  PMID: 8792543

Full text

PDF
122

Images in this article

123Image
on p.123
123Image
on p.123
125Image
on p.125
126Image
on p.126

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bax J. J., Visser F. C., van Lingen A., Visser C. A., Teule G. J. Myocardial F-18 fluorodeoxyglucose imaging by SPECT. Clin Nucl Med. 1995 Jun;20(6):486–490. doi: 10.1097/00003072-199506000-00002. [DOI] [PubMed] [Google Scholar]
  2. Bisi G., Sciagrà R., Santoro G. M., Fazzini P. F. Rest technetium-99m sestamibi tomography in combination with short-term administration of nitrates: feasibility and reliability for prediction of postrevascularization outcome of asynergic territories. J Am Coll Cardiol. 1994 Nov 1;24(5):1282–1289. doi: 10.1016/0735-1097(94)90110-4. [DOI] [PubMed] [Google Scholar]
  3. Bonow R. O., Dilsizian V., Cuocolo A., Bacharach S. L. Identification of viable myocardium in patients with chronic coronary artery disease and left ventricular dysfunction. Comparison of thallium scintigraphy with reinjection and PET imaging with 18F-fluorodeoxyglucose. Circulation. 1991 Jan;83(1):26–37. doi: 10.1161/01.cir.83.1.26. [DOI] [PubMed] [Google Scholar]
  4. Chua T., Kiat H., Germano G., Maurer G., van Train K., Friedman J., Berman D. Gated technetium-99m sestamibi for simultaneous assessment of stress myocardial perfusion, postexercise regional ventricular function and myocardial viability. Correlation with echocardiography and rest thallium-201 scintigraphy. J Am Coll Cardiol. 1994 Apr;23(5):1107–1114. doi: 10.1016/0735-1097(94)90598-3. [DOI] [PubMed] [Google Scholar]
  5. Cooke C. D., Garcia E. V., Cullom S. J., Faber T. L., Pettigrew R. I. Determining the accuracy of calculating systolic wall thickening using a fast Fourier transform approximation: a simulation study based on canine and patient data. J Nucl Med. 1994 Jul;35(7):1185–1192. [PubMed] [Google Scholar]
  6. DePuey E. G., Nichols K., Dobrinsky C. Left ventricular ejection fraction assessed from gated technetium-99m-sestamibi SPECT. J Nucl Med. 1993 Nov;34(11):1871–1876. [PubMed] [Google Scholar]
  7. DePuey E. G., Rozanski A. Using gated technetium-99m-sestamibi SPECT to characterize fixed myocardial defects as infarct or artifact. J Nucl Med. 1995 Jun;36(6):952–955. [PubMed] [Google Scholar]
  8. Dilsizian V., Rocco T. P., Freedman N. M., Leon M. B., Bonow R. O. Enhanced detection of ischemic but viable myocardium by the reinjection of thallium after stress-redistribution imaging. N Engl J Med. 1990 Jul 19;323(3):141–146. doi: 10.1056/NEJM199007193230301. [DOI] [PubMed] [Google Scholar]
  9. Favaro L., Masini F., Serra W., Gavaruzzi G., Benecchi G., Tagliavini S., Botti G. Thallium 201 for detection of viable myocardium: comparison of different reinjection protocols. J Nucl Cardiol. 1994 Nov-Dec;1(6):515–521. doi: 10.1007/BF02939974. [DOI] [PubMed] [Google Scholar]
  10. Kelly M. J., Kalff V. Fluorine 18-labeled fluorodeoxyglucose myocardial scintigraphy with Anger gamma cameras for assessing myocardial viability. J Nucl Cardiol. 1995 Jul-Aug;2(4):360–365. doi: 10.1016/s1071-3581(05)80083-2. [DOI] [PubMed] [Google Scholar]
  11. Leichner P. K., Morgan H. T., Holdeman K. P., Harrison K. A., Valentino F., Lexa R., Kelly R. F., Hawkins W. G., Dalrymple G. V. SPECT imaging of fluorine-18. J Nucl Med. 1995 Aug;36(8):1472–1475. [PubMed] [Google Scholar]
  12. Lomboy C. T., Schulman D. S., Grill H. P., Flores A. R., Orie J. E., Granato J. E. Rest-redistribution thallium-201 scintigraphy to determine myocardial viability early after myocardial infarction. J Am Coll Cardiol. 1995 Jan;25(1):210–217. doi: 10.1016/0735-1097(94)00350-y. [DOI] [PubMed] [Google Scholar]
  13. Marcassa C., Marzullo P., Parodi O., Sambuceti G., L'Abbate A. A new method for noninvasive quantitation of segmental myocardial wall thickening using technetium-99m 2-methoxy-isobutyl-isonitrile scintigraphy--results in normal subjects. J Nucl Med. 1990 Feb;31(2):173–177. [PubMed] [Google Scholar]
  14. Pryor D. B., Harrell F. E., Jr, Lee K. L., Califf R. M., Rosati R. A. An improving prognosis over time in medically treated patients with coronary artery disease. Am J Cardiol. 1983 Sep 1;52(5):444–448. doi: 10.1016/0002-9149(83)90004-8. [DOI] [PubMed] [Google Scholar]
  15. Udelson J. E., Coleman P. S., Metherall J., Pandian N. G., Gomez A. R., Griffith J. L., Shea N. L., Oates E., Konstam M. A. Predicting recovery of severe regional ventricular dysfunction. Comparison of resting scintigraphy with 201Tl and 99mTc-sestamibi. Circulation. 1994 Jun;89(6):2552–2561. doi: 10.1161/01.cir.89.6.2552. [DOI] [PubMed] [Google Scholar]

Articles from Texas Heart Institute Journal are provided here courtesy of Texas Heart Institute

RESOURCES